Continuous Low-Dose Oral Chemotherapy for Adjuvant Therapy of Splenic Hemangiosarcoma in Dogs - Concepedia

Concepedia

Publication | Closed Access

Continuous Low-Dose Oral Chemotherapy for Adjuvant Therapy of Splenic Hemangiosarcoma in Dogs

117

Citations

30

References

2007

Year

Susan E. Lana, Lance U’Ren, Susan Plaza, Robyn Elmslie, Daniel L. Gustafson, Paul S. Morley, Steven Dow

Journal of Veterinary Internal Medicine

Abstract

Continuous orally administered LDC may be an effective alternative to conventional high-dose chemotherapy for adjuvant therapy of dogs with HSA.

References

	Year	Citations

Page 1